4//SEC Filing
Reeve Emma 4
Accession 0001680329-25-000008
CIK 0001070081other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 5:20 PM ET
Size
10.1 KB
Accession
0001680329-25-000008
Insider Transaction Report
Form 4
Reeve Emma
Director
Transactions
- Sale
Common Stock
2025-10-30$69.50/sh−12,000$834,000→ 6,666 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-30−12,000→ 0 totalExercise: $38.10Exp: 2032-01-06→ Common Stock (12,000 underlying) - Sale
Common Stock
2025-10-30$69.50/sh−3,666$254,787→ 6,666 total - Exercise/Conversion
Common Stock
2025-10-30$38.10/sh+12,000$457,200→ 18,666 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.
- [F2]Currently exercisable.
Documents
Issuer
PTC THERAPEUTICS, INC.
CIK 0001070081
Entity typeother
Related Parties
1- filerCIK 0001680329
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 5:20 PM ET
- Size
- 10.1 KB